Laura L. Sutherland

Duke University — United States

Immunology and Microbiology · Life Sciences

37h-index5.4kcitations75works11.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(45), Immune Cell Function and Interaction(25), T-cell and B-cell Immunology(15), SARS-CoV-2 and COVID-19 Research(14), HIV/AIDS drug development and treatment(14)

Publications75 total

Transient regulatory T cell manipulation is limited by anti-antibody responses in HIV-1 envelope immunized rhesus macaques
iScience·2025Open Access
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates
Science Translational Medicine·2025· 1 cited
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
Vaccines·2025· 3 citedOpen Access
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env–ferritin nanoparticle designs
Journal of Virology·2024· 5 citedOpen Access
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques
Cell·2024· 48 citedOpen Access
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates
2023· 6 citedOpen Access
Vaccine induction of CD4-mimicking broadly neutralizing antibody precursors in macaques
2023· 3 citedOpen Access
Vaccine Induction of CD4-Mimicking Broadly Neutralizing Antibody Precursors in Macaques
SSRN Electronic Journal·2023· 1 citedOpen Access
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Nature Communications·2022· 70 citedOpen Access
Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection
Science Translational Medicine·2022· 37 citedOpen Access
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine
2022· 15 citedOpen Access
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine
SSRN Electronic Journal·2022· 7 citedOpen Access
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
UNC Libraries·2021· 19 citedOpen Access
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Cell·2021· 325 citedOpen Access
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates
PLoS Pathogens·2021· 3 citedOpen Access
Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates
Proceedings of the National Academy of Sciences·2021· 26 citedOpen Access
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
Nature·2021· 269 citedOpen Access
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
npj Vaccines·2021· 82 citedOpen Access
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys
2021· 14 citedOpen Access
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center
npj Vaccines·2021· 5 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

David C. Montefiori(38), Barton F. Haynes(36), Robert Parks(31), S. Munir Alam(30), Richard M. Scearce(29), Sampa Santra(29), M. Anthony Moody(24), Kevin O. Saunders(23), Hua‐Xin Liao(20), Mark G. Lewis(18), Georgia D. Tomaras(17), Kevin Wiehe(16), Amanda Eaton(15), Derek W. Cain(12), Robert J. Edwards(12), Maggie Barr(12), Wes Rountree(12), Drew Weissman(11), Bette Korber(11), Katayoun Mansouri(11)